The SHPA has joined forces with the Royal Pharmaceutical Society, cooperating to deliver advanced practice accreditation that is recognised in both countries
The Society of Hospital Pharmacists of Australia says the signing of an historic new agreement will see the RPS and the SHPA collaborating to deliver quality-assured education, training and development opportunities mapped to pharmacist career stages in the UK and Australia.
This includes mutually accredited, two-year advanced practice specialist residencies for pharmacists across a range of practice areas.
SHPA President Professor Michael Dooley says accreditation of advanced practice residency sites in Australia will begin next year.
“Building a workforce that can deliver a high standard of care across different settings and sectors – hospitals, community, care homes or general practice – while drawing on advanced knowledge of how to best manage complex patient needs is a shared goal of RPS and SHPA,” says Professor Dooley.
“We look forward to progressing this initiative with applications opening in October 2018 and the first intake of pharmacists to the advanced practice residences taking place in 2019.”
RPS Director Catherine Duggan says the partnership acknowledges research on international workforce co-development.
“Working together will allow us to share expertise across defined areas of pharmacy practice, delivering mutually beneficial programmes and services.
“Previous work by the International Pharmaceutical Federation (FIP) has shown that, at foundation level, there exists a common set of practice-related competencies that are globally applicable.”
Professor Dooley says the SHPA “look[s] forward to progressing this exciting initiative over the next two years, broadening opportunities for Australian pharmacists who will have their SHPA credentials recognised in the UK, via the RPS, and vice versa.”
“By committing to developing mutually accredited training and development programmes we believe we can build a transformational model that could be adopted across many countries in the future.”
Note: The original article mistakenly stated that the new agreement would be providing opportunities for Australian hospital pharmacists to train and work in the UK. In fact, the new agreement will allow the two organisations to deliver advanced practice accreditation that is recognised in both countries.